US stocks slip ahead of Fed announcement on interest rates and crude oil prices rise again

U.S. stocks were slightly lower ahead of the Federal Reserve's afternoon rate decision, with the S&P 500 down 0.2%, the Dow off 97 points, and the Nasdaq down 0.4%. Oil prices continued to surge on the Iran war, with Brent crude up 5% to $116.80 for June delivery and July Brent up 4.9% to $109.51, reinforcing expectations that the Fed will hold rates steady. Earnings were mixed but mostly supportive: Visa rose 10% and Starbucks gained 4.6% on beats, while GE Healthcare fell 12.3%, Robinhood dropped 11.2%, and Booking fell 2.4% on war-related travel pressure.

Analysis

The market is pricing a messy cross-current where the obvious winners are defensive quality and pricing power, while the real risk sits in duration-sensitive multiples. With oil and yields both moving up, the first-order hit is to earnings multiples rather than earnings estimates: that is most painful for crowded long-duration growth and levered financial intermediaries whose business lines depend on turnover but not necessarily on spread expansion. The tape is telling us the market is rewarding companies that can pass through inflation or already sit inside the transaction flow rather than those whose value depends on cheap capital and stable volatility.

The earnings reactions also highlight a dispersion regime, not a broad consumer slowdown. Payments and premium discretionary are being rewarded when they can prove spend resilience, which suggests the next leg of the cycle is less about demand destruction and more about share gains among the best-executing platforms. By contrast, travel is the cleaner second-order loser because geopolitics hits both willingness to book and route economics; even where results beat, forward guidance is what gets de-rated first. That makes travel a better short on forward revisions than on current-quarter numbers.

The overhang from energy is increasingly about inflation persistence, not just gasoline at the pump. If crude stays elevated for another few weeks, the Fed’s reaction function likely shifts from ‘pause’ to ‘higher for longer,’ which re-prices all assets with embedded duration. The contrarian angle is that this could ultimately be bullish for select financials and payment rails if consumer nominal spending stays intact, but only after the initial multiple compression passes; near term, the market is more likely to punish anything where high rates and high oil compress optionality at once.

Key Decisions for Investors

• Stay long V on any post-earnings retrace for a 2-6 week hold; it screens as a relative winner if nominal consumer spend remains resilient and rates stay elevated, with downside mainly limited to a broad market multiple reset.
• Initiate a tactical short or put spread in BKNG for 1-2 months; the thesis is not current demand collapse but forward guidance de-rating if war-driven route disruptions persist into the next booking window.
• Fade HOOD on rallies over the next several sessions; it is structurally more exposed to a high-rate / risk-off mix than the headline earnings miss suggests, with asymmetric downside if retail trading activity normalizes lower.
• Use GEHC weakness as a relative-value short versus higher-quality medtech/healthcare names for 1-3 months; the market is likely to reward execution visibility and punish any hint of demand or margin fragility.
• Consider a pairs trade: long V / short HOOD or long SBUX / short BKNG, aiming to isolate businesses with proven spend resilience from those most exposed to volatility in consumer confidence and travel intent.